Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Busse

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Allergy|April 23, 2020
Type 2 immunity in the skin and lungsCezmi A Akdis, Peter D Arkwright, Marie-Charlotte Brüggen, et al.
Sleep & Breathing = Schlaf & Atmung|November 22, 2011
Sleep quality and asthma control and quality of life in non-severe and severe asthmaFaith S Luyster, Mihaela Teodorescu, Eugene Bleecker, et al.
Annals of Internal Medicine|May 4, 2011
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trialNicola A Hanania, Oral Alpan, Daniel L Hamilos, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2013
Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research ProgramKenneth Wysocki, Seo Young Park, Eugene Bleecker, et al.
ERJ Open Research|March 9, 2023
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial designLucia De Prado Gomez, Ian Pavord, William Busse, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2010
Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research ProgramChristy Gamble, Evelyn Talbott, Ada Youk, et al.
The Lancet. Respiratory Medicine|April 5, 2026
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 studyJorge F Maspero, Ian D Pavord, Michael E Wechsler, et al.
The American Journal of Clinical Nutrition|April 19, 2013
Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescentsPeter J Gergen, Stephen J Teach, Herman E Mitchell, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2010
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthmaRaed A Dweik, Ronald L Sorkness, Sally Wenzel, et al.
Academic Radiology|July 15, 2014
Longitudinal changes in airway remodeling and air trapping in severe asthmaChad A Witt, Ajay Sheshadri, Luke Carlstrom, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Allergy|April 23, 2020
Type 2 immunity in the skin and lungsCezmi A Akdis, Peter D Arkwright, Marie-Charlotte Brüggen, et al.
Sleep & Breathing = Schlaf & Atmung|November 22, 2011
Sleep quality and asthma control and quality of life in non-severe and severe asthmaFaith S Luyster, Mihaela Teodorescu, Eugene Bleecker, et al.
Annals of Internal Medicine|May 4, 2011
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trialNicola A Hanania, Oral Alpan, Daniel L Hamilos, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2013
Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research ProgramKenneth Wysocki, Seo Young Park, Eugene Bleecker, et al.
ERJ Open Research|March 9, 2023
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial designLucia De Prado Gomez, Ian Pavord, William Busse, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2010
Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research ProgramChristy Gamble, Evelyn Talbott, Ada Youk, et al.
The Lancet. Respiratory Medicine|April 5, 2026
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 studyJorge F Maspero, Ian D Pavord, Michael E Wechsler, et al.
The American Journal of Clinical Nutrition|April 19, 2013
Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescentsPeter J Gergen, Stephen J Teach, Herman E Mitchell, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2010
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthmaRaed A Dweik, Ronald L Sorkness, Sally Wenzel, et al.
Academic Radiology|July 15, 2014
Longitudinal changes in airway remodeling and air trapping in severe asthmaChad A Witt, Ajay Sheshadri, Luke Carlstrom, et al.
Pageof 5